ABSTRACT
Background: Aniseikonia is a binocular vision disorder that has been associated with asthenopic symptoms. However, asthenopia has been evaluated with subjective tests that make difficult to determine the level of aniseikonia. This study aims to objectively evaluate the impact of induced aniseikonia at different levels on visual fatigue by measuring the orbicularis oculi muscle activity in the dominant and non-dominant eyes while performing a reading task. Methods: Twenty-four collegiate students (24.00 ± 3.86 years) participated in this study. Participants read a passage for 7 minutes under four degrees of aniseikonia (0%, 3%, 5% and 10%) at 50 cm. Orbicularis oculi muscle activity of the dominant and non-dominant eye was recorded by surface electromyography. In addition, visual discomfort was assessed after each task by completing a questionnaire. Results: Orbicularis oculi muscle activity increased under induced aniseikonia (i.e., greater values for the 10% condition in comparison to 0%, and 3% conditions (p = 0.034 and p = 0.023, respectively)). No statistically significant differences were observed in orbicularis oculi muscle activity for the time on task and between the dominant and non-dominant eyes. Additionally, higher levels of subjective visual discomfort were observed for lower degrees of induced aniseikonia. Conclusion: Induced aniseikonia increases visual fatigue at high aniseikonia degrees as measured by the orbicularis oculi muscle activity, and at low degrees as measured with subjective questionnaires. These findings may be of relevance to better understand the visual symptomatology of aniseikonia.
Subject(s)
Aniseikonia , Electromyography , Reading , Humans , Male , Female , Young Adult , Adult , Aniseikonia/physiopathology , Oculomotor Muscles/physiology , Asthenopia/physiopathology , Asthenopia/etiology , Computers , Facial Muscles/physiologyABSTRACT
Even after idiopathic macular hole (MH) surgery and with successful closure of MH, aniseikonia is a common postoperative symptom. We investigated the correlation of MH diameter, retinal displacement and retinal layer thicknesses with aniseikonia in 41 eyes of 41 patients undergoing MH surgery with internal limiting membrane peeling. Aniseikonia was measured with the New Aniseikonia Test. Retinal displacement (RD%) was defined as change of retinal distance between the temporal margin of the optic papilla and the intersection of the retinal vessels. Changes of thicknesses of the inner nuclear layer (INL%) and the outer retinal layer (OR%) were calculated. Aniseikonia improved postoperatively. Preoperative aniseikonia and their improvement at 6 months correlated with MH diameters (P = 0.004-0.046). Improvement of aniseikonia correlated with temporal RD% (P = 0.002-0.012). Improvement of vertical aniseikonia correlated with INL% at 2 weeks and with the nasal OR% at 1, 3, and 6 months (P = < 0.001-0.028). MH diameter and age were significant predictors for improvement of aniseikonia. The greater the temporal retina displacement, and the thinner the postoperative INL and OR, the greater the improvement of aniseikonia. MH diameter and age are strong predictors for improvement of aniseikonia after MH surgery.
Subject(s)
Aniseikonia , Epiretinal Membrane , Retinal Perforations , Humans , Retinal Perforations/surgery , Retinal Perforations/diagnosis , Aniseikonia/surgery , Epiretinal Membrane/surgery , Visual Acuity , Vitrectomy , Tomography, Optical Coherence , Retina/surgery , Retrospective StudiesABSTRACT
CLINICAL RELEVANCE: Binocular visual acuity is an important index of functional performance. Optometrists need to know how binocular visual acuity is affected by aniseikonia, and whether reduced binocular visual acuity is a marker for aniseikonia. BACKGROUND: Aniseikonia, the perception of unequal image sizes between the eyes, can occur spontaneously or can be induced after different types of eye surgery, or trauma. It is known to affect binocular vision, but there are no prior studies about how it affects visual acuity. METHODS: Visual acuity was measured for 10 healthy well-corrected participants aged 18-21 years of age. Aniseikonia of up to 20% was induced in one of two ways: (1) size lenses, which provided minification of field of view in one eye of each participant and (2) polaroid filters, which allowed vectographic viewing of optotypes on a 3D computer monitor. The best corrected acuity was measured on conventional logarithmic progression format vision charts and isolated optotypes, under both induced aniseikonia conditions. RESULTS: Induced aniseikonia caused binocular visual acuity thresholds to increase by small but statistically significant amounts, with the largest deficit being 0.06 logMAR for 20% size differences between the eyes. Binocular visual acuity was worse than monocular visual acuity for aniseikonia of 9% and greater. Acuity measured with the vectographic presentation gave slightly higher thresholds (by 0.01 logMAR) than for those viewed with size lenses. Acuity measured with charts gave slightly higher thresholds (by 0.02 logMAR) than with isolated letters. CONCLUSION: An acuity change of 0.06 logMAR is small and may be missed in a clinical examination. Therefore, visual acuity cannot be used as a marker of aniseikonia in clinical settings. Even with very marked induced aniseikonia, binocular visual acuity remained well within standards for licen*c*sing of drivers.
Subject(s)
Aniseikonia , Humans , Adolescent , Young Adult , Adult , Aniseikonia/diagnosis , Aniseikonia/etiology , Visual Acuity , Vision, Ocular , Vision, Binocular , EyeABSTRACT
This study investigated aniseikonia after reduced-fluence photodynamic therapy (RFPDT) for central serous chorioretinopathy (CSC). We examined 48 eyes of 48 patients (38 men; mean age, 49.2 ± 9.9 years) with CSC resolved after RFPDT. Horizontal and vertical aniseikonia were measured using the New Aniseikonia Test at baseline, 6 months, and 12 months after RFPDT. The maximum absolute value of the horizontal and vertical measurements indicated the aniseikonia score. The aniseikonia score was 2.2 ± 2.3 at 6 months and 2.2 ± 2.0 at 12 months after RFPDT, both of which improved significantly from the baseline score of 4.1 ± 2.9 (P < 0.05 and P < 0.01, respectively). The 12-month aniseikonia score significantly correlated with the baseline aniseikonia score (P = 0.047), outer nuclear thickness at baseline (P = 0.027) and 12 months after RFPDT (P = 0.014), baseline SRD area (P = 0.005), and ellipsoid zone disruption at 12 months after RFPDT (P = 0.021). In multivariate analysis, baseline serous retinal detachment (SRD) area (P = 0.034) was significantly associated with aniseikonia score at 12 months after RFPDT. Eyes with a larger SRD area might have higher aniseikonia scores even after SRD resolution following RFPDT.
Subject(s)
Aniseikonia , Central Serous Chorioretinopathy , Photochemotherapy , Porphyrins , Retinal Detachment , Male , Humans , Adult , Middle Aged , Central Serous Chorioretinopathy/drug therapy , Photosensitizing Agents/therapeutic use , Retinal Detachment/drug therapy , Tomography, Optical Coherence , Fluorescein Angiography , Retrospective Studies , Porphyrins/therapeutic useABSTRACT
PURPOSE: To assess the risk of retinal displacement after scleral buckle (SB) versus pars plana vitrectomy with SB (PPV-SB). DESIGN: Multicenter prospective nonrandomized clinical trial. METHODS: The study took place at VitreoRetinal Surgery in Minneapolis, Minnesota, Sankara Nethralaya in Chennai, India, and St. Michael's Hospital in Toronto, Canada from July 2019 to February 2022. Patients who underwent successful SB or PPV-SB for fovea-involving rhegmatogenous retinal detachment with gradable postoperative fundus autofluorescence (FAF) imaging were included in the final analysis. Two masked graders assessed FAF images 3 months postoperatively. Metamorphopsia and aniseikonia were assessed with M-CHARTs and the New Aniseikonia Test, respectively. The primary outcome was the proportion of patients with retinal displacement detected with retinal vessel printings on FAF in SB versus PPV-SB. RESULTS: Ninety-one eyes were included in this study, of which 46.2% (42 of 91) had SB and 53.8% (49 of 91) underwent PPV-SB. Three months postoperatively, 16.7% (7 of 42) in the SB group and 38.8% (19 of 49) in the PPV-SB group had evidence of retinal displacement (difference = 22.1%; odds ratio = 3.2; 95% confidence interval [CI], 1.2-8.6; P = 0.02) on FAF. The statistical significance of this association increased after adjustment for extent of retinal detachment, baseline logarithm of the minimum angle of resolution, lens status, and sex in a multivariate regression analysis (P = 0.01). Retinal displacement was detected in 22.5% (6 of 27) of patients in the SB group with external subretinal fluid drainage and 6.7% (1 of 15) of patients without external drainage (difference = 15.8%; odds ratio = 4.0; 95% CI, 0.4-36.9; P = 0.19). Mean vertical metamorphopsia, horizontal metamorphopsia (MH), and aniseikonia were similar between patients in the SB and PPV-SB groups. There was a trend to worse MH in patients with retinal displacement versus those without retinal displacement (P = 0.067). CONCLUSIONS: Scleral buckle is associated with less retinal displacement compared with PPV-SB, indicating that traditional PPV techniques cause retinal displacement. There is a trend toward increased risk of retinal displacement in SB eyes that underwent external drainage compared with SB eyes without drainage, which is consistent with our understanding that the iatrogenic movement of subretinal fluid, such as that which occurs intraoperatively during external drainage with SB, may induce retinal stretch and displacement if the retina is then fixed in the stretched position. There was a trend to worse MH at 3 months in patients with retinal displacement. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Subject(s)
Aniseikonia , Retinal Detachment , Humans , Retinal Detachment/diagnosis , Retinal Detachment/etiology , Retinal Detachment/surgery , Vitrectomy/adverse effects , Vitrectomy/methods , Prospective Studies , Aniseikonia/complications , Aniseikonia/surgery , Treatment Outcome , Visual Acuity , India , Retina/surgeryABSTRACT
SIGNIFICANCE: The determination of aniseikonia tolerance may aid in developing optimal treatment plans for cataract surgery, refractive surgery, and refractive correction with glasses and contact lenses. PURPOSE: This study aimed to measure aniseikonia tolerance. METHODS: We included 33 patients (mean age ± standard deviation, 28.9 ± 6.4 years; male/female, 12:21) with anisometropia ≤1.0 D and best spectacle-corrected visual acuity of 20/20 or more in both eyes, with no ophthalmologic disease other than refractive errors and no history of ocular surgery. The exclusion criteria were anisometropia >1.0 D, axial length difference >0.5 mm, corneal refractive power difference >0.5 D, astigmatism >3.0 D, stereoacuity threshold >100 arcsec according to the Titmus Stereo Test, and >0% aniseikonia according to the New Aniseikonia Test. Aniseikonia tolerance was assessed using Eyemark Hello, a haploscope using gaze detection technology. Although the optotype of one eye was enlarged or reduced at a speed of 2%/s, the patients were instructed to press a button on the controller to indicate blurring, flickering, and diplopia. The value at which the patient responded was considered the aniseikonia tolerance value and assessed thrice per eye, five times if the values were highly variable, and then averaged. RESULTS: The mean aniseikonia tolerance was approximately 3%; the median value was approximately 2% (range, 1.0 to 11.5%; dominant eye, 3.3 ± 2.6%; nondominant eye, 2.9 ± 1.8%). No significant difference in aniseikonia tolerance between the dominant and nondominant eyes was observed for the enlarged optotypes. No case showed changes in the ocular alignment before discomfort occurred. No significant correlation was observed between aniseikonia tolerance and anisometropia, axial length difference, corneal power difference, and ocular deviation. CONCLUSIONS: Aniseikonia should be maintained at <2% for a comfortable visual environment. Aniseikonia tolerance may be an important indicator for cataract surgery, refractive surgery, and spectacle correction.
Subject(s)
Aniseikonia , Anisometropia , Cataract Extraction , Cataract , Refractive Errors , Humans , Male , Female , Aniseikonia/diagnosis , Anisometropia/diagnosisABSTRACT
PURPOSE: To compare foveal avascular zone (FAZ) geometric indices using optical coherence tomography angiography (OCTA) in pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD). FAZ morphology was assessed as a possible imaging feature of retinal displacement. METHODS: This ALIGN post hoc analysis included primary fovea-off RRDs that underwent successful PnR or PPV, and performed OCTA, and fundus autofluorescence at (FAF) 3 months postoperatively at St. Michael's Hospital, Toronto, Canada. FAZ area (mm 2 ), axial ratio, circularity, and roundness were measured, and FAF images were assessed for retinal displacement. RESULTS: Seventy-two patients were included, 78% (56/72) were male mean age was 60 ± 9 years, and 60% (43/72) were phakic. Sixty-five percent (47/72) and 35% (25/72) underwent PnR and PPV, respectively. The mean baseline logarithm of the minimum angle of resolution visual acuity was 1.49 ± 0.76. FAZ circularity was lower after PPV (0.629 ± 0.120) versus PnR (0.703 ± 0.122); P = 0.016. Sixty-six patients had gradable FAF images. Retinal displacement was present in 29% (19/66), 84.2% (16/19) of which had displacement in the macula. FAZ circularity was lower in eyes with displacement in the macula (0.613 ± 0.110) versus those without displacement (0.700 ± 0.124); P = 0.015. There was a moderate negative correlation between 12-month aniseikonia and FAZ circularity(r = -0.262; P = 0.041). CONCLUSION: FAZ circularity was lower after PPV and in eyes with retinal displacement in the macula. Circularity was negatively correlated with 12-month aniseikonia scores. FAZ circularity may be another imaging feature to consider postoperatively after RRD repair.
Subject(s)
Aniseikonia , Macula Lutea , Retinal Detachment , Humans , Male , Middle Aged , Aged , Female , Retinal Detachment/diagnosis , Retinal Detachment/surgery , Tomography, Optical Coherence/methods , Fluorescein Angiography/methods , Vitrectomy/methods , Retrospective StudiesABSTRACT
PURPOSE: To investigate the long-term changes in visual function and outer retinal abnormalities on en face optical coherence tomography after fovea-off rhegmatogenous retinal detachment and to assess associations between functional outcomes and outer retinal abnormalities. METHODS: Prospective, observational study. The following data were collected at 1, 3, 6, 12, and 24 months after retinal reattachment: Best-corrected visual acuity, metamorphopsia (M-CHARTS), aniseikonia (New Aniseikonia Test), altered ellipsoid zone reflectivity, outer retinal folds, macular detachment demarcation, and subfoveal fluid. RESULTS: Thirty-eight patients were included. Best-corrected visual acuity improved significantly from 1 to 12 months and from 12 to 24 months (P < 0.001; P = 0.022). Vertical and horizontal metamorphopsia improved significantly from 1 to 12 months (P < 0.001; P = 0.002), and at 24 months, scores of ≥0.2° were present in 54% and 42% of patients, respectively. The degree of aniseikonia did not change. Best-corrected visual acuity and aniseikonia scores were positively associated with outer retinal fold (r 0.4, P = 0.009; r 0.4, P = 0.048). A gradual normalization of outer retinal reflectivity took place during 24 months. CONCLUSION: Visual acuity improved significantly during the second year after reattachment surgery for fovea-off rhegmatogenous retinal detachment, in parallel with normalization of outer retinal abnormalities on en face optical coherence tomography. Metamorphopsia did not improve after 12 months, and aniseikonia remained unchanged.
Subject(s)
Aniseikonia , Retinal Detachment , Humans , Retinal Detachment/diagnosis , Retinal Detachment/surgery , Tomography, Optical Coherence/methods , Prospective Studies , Vision Disorders , VitrectomySubject(s)
Humans , Optometry , Optics and Photonics , Refractive Errors , Anisometropia , AniseikoniaABSTRACT
Purpose: To provide a tool for calculating radial and tangential retinal magnifications as functions of field angle and retinal shape and to articulate patterns of magnification across the retina for monocular and binocular combinations of prolate-, oblate-, and spherical-shaped retinas. Methods: Formulae were derived to calculate radial and tangential retinal magnifications (mm/deg) from field angle (degrees), retinal asphericity (unitless conic constant), retinal vertex radius of curvature (mm), and nodal point position (mm). Monocular retinal magnifications were determined for eyes with prolate, spherical, and oblate retinas as functions of field angle. Bilateral differences in magnifications were examined for combinations of those eyes. Results: Retinal shape substantially affects magnification profiles even for eyes with the same axial length. Greatest magnification changes across a retina and between eyes, as well as greatest increase in radial-tangential differences (distortion), occur with prolate retinas. Binocular magnification differences were smallest for oblate retinas. Nodal points anterior to the vertex center of curvature and oblate asphericity both cause field-dependent reductions in magnification relative to the fovea (barrel distortion), whereas nodal points posterior to vertex center of curvature and prolate asphericity cause the opposite (pincushion distortion). Retinal magnification differences due to eye shape are much greater than aniseikonia thresholds and chromatic differences in magnification. A spreadsheet tool implements the magnification calculations. Conclusions: Local retinal magnifications as functions of field angle have substantial effects on objective applications (imaging retinal anatomy) and subjective experiences (aniseikonia) and quantify an ocular property that differs across eye shapes and refractive errors. Translational Relevance: Methods are provided to customize the calculation of radial and tangential magnifications across the retina for individual eyes, which will bolster the multifactorial study of the effects of foveal and peripheral optics across eye shapes and refractive errors.
Subject(s)
Aniseikonia , Phosmet , Refractive Errors , Humans , Radius , Retina/diagnostic imaging , Visual FieldsABSTRACT
The visual system is highly complex. Monocular or binocular disorders can develop, for example during tractive alterations of the macula, such as in epimacular membranes, and result in symptoms, such as double vision, aniseikonia or metamorphopsia. These symptoms are also observed following vitreomacular or vitreoretinal surgery, especially after treatment of large retinal detachment involving the macular area using pars plana vitrectomy or scleral buckle surgery but also as a result of vitreomacular interventions, such as membrane peeling in epimacular gliosis. Some patients have preoperatively existing latent conditions, which are not explicitly addressed during routine preoperative diagnostics. For patients and surgeons it is worth noting that these troublesome symptoms are often manifested in patients with good restoration of best corrected visual acuity following vitreomacular surgery. In such cases, patients tend to be dissatisfied with the surgical result despite good visual acuity. Treatment of postoperative metamorphopsia, aniseikonia and double vision is often difficult. In clinical studies, the maximum depth of tractive retinal folds has been described as a reliable morphological biomarker for the occurrence of metamorphopsia in epimacular gliosis. As metamorphopsia tends to postoperatively resolve slowly and even persist in ca. 30% of cases, this biomarker can have an impact on preoperative consulting and postoperative monitoring. Persistent binocular discomfort is often treatable by exact refraction correction and by applying a vertical and, if necessary, a horizontal prism. This often requires patience on the part of both the patient and the physician but is mostly successful due to fusion and adaptability.
Subject(s)
Aniseikonia , Diplopia , Gliosis/diagnosis , Humans , Vision Disorders/diagnosis , Visual AcuityABSTRACT
BACKGROUND: Ocular magnification and aniseikonia after cataract surgery has been widely ignored in modern cataract surgery. The purpose of this study was to analyse ocular magnification and inter-individual differences in a normal cataract population with a focus on monovision. METHODS: From a large dataset containing biometric measurements (IOLMaster 700) of both eyes of 9734 patients prior to cataract surgery, eyes were indexed randomly as primary (P) and secondary (S). Intraocular lens power (IOLP) was derived for the HofferQ, Haigis and Castrop formulae for emmetropia for P and emmetropia or myopia (-0.5 to -2 dpt) for S to simulate monovision. Based on the pseudophakic eye model in addition to these formulae, ocular magnification was extracted using matrix algebra (refraction and translation matrices and a system matrix describing the optical property of the entire spectacle corrected or uncorrected eye). RESULTS: With emmetropia for P and S the IOLP differences (S-P) showed a standard deviation of 0.162/0.156/0.157 dpt and ocular magnification differences yielded a standard deviation of 0.0414/0.0405/0.0408 mm/mrad for the HofferQ/Haigis/Castrop setting. Simulating monovision, the myopic eye (S) showed a systematically smaller mean absolute spectacle corrected ocular magnification than the emmetropic eye (-0.0351/-0.0340/-0.0336, respectively, relative magnification around 2%). If myopia in the S eye remains uncorrected, the reduction of ocular magnification is much smaller (around 0.2-0.3%). CONCLUSION: Vergence formulae for IOLP calculation sometimes implicitly define a pseudophakic eye model which can be directly used to predict ocular magnification after cataract surgery. Despite a strong similarity of both eyes, ocular magnification does not fully match between eyes and the prediction of ocular magnification and aniseikonia might be relevant to avoid eikonic problems in the pseudophakic eye.
Subject(s)
Aniseikonia , Cataract , Lenses, Intraocular , Myopia , Humans , Aniseikonia/diagnosis , Aniseikonia/etiology , Refraction, Ocular , Myopia/surgery , Biometry , Cataract/diagnosis , Optics and Photonics , Retrospective StudiesABSTRACT
BACKGROUND: Aniseikonia represents a potential barrier to neuroplasticity which may limit visual outcomes in children with anisometropic amblyopia. Full correction of refractive error is the first step in standard amblyopia treatment, which corrects for image focus but neglects image size differences. METHODS: The MAGNIFY study is a double-masked, randomised clinical trial investigating the effectiveness of aniseikonia correcting lenses in children at first diagnosis of significant anisometropia. We hypothesis that aniseikonia correction lenses will improve image clarity and reduce the retinal size differences producing better visual acuity and stereoacuity improvements after 15 weeks of optical treatment for children with anisometropia. Eligible children will be randomly allocated to the treatment group (aniseikonia-correcting spectacle lenses) or control group (standard spectacle lenses). Visual acuity and binocular functions will be assessed every 5 weeks during the 15-week optical treatment phase according to standard amblyopia treatment protocol. DISCUSSION: It is possible that correcting aniseikonia along with anisometropia at first diagnosis will promote binocularity as well as increase spectacle adherence by reducing visual discomfort, improving optical treatment outcomes. This could then reduce the need for additional amblyopia treatment such as patching or atropine, reducing the burden on hospital eye departments and potentially improving visual outcomes for children with amblyopia. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620000061932 . Registered on 24 January 2020. Protocol 15th November 2019, version one.
Subject(s)
Amblyopia , Aniseikonia , Anisometropia , Amblyopia/diagnosis , Amblyopia/therapy , Aniseikonia/diagnosis , Anisometropia/therapy , Australia , Child , Humans , Neuronal Plasticity , Randomized Controlled Trials as TopicABSTRACT
PURPOSE: To simulate both lens-induced and screen-induced aniseikonia, and to assess its influence on stereopsis. Additionally, to determine if screen-based size differences could neutralise the effects of lens-induced aniseikonia. METHOD: A four-circle (4-C) paradigm was developed, where one circle appears in front or behind the others because of crossed or uncrossed disparity. This stereotest was used for three investigations: (1) Comparison with the McGill modified random dot stereogram (RDS), with anisometropia introduced with +2 D spheres and cylinders, and with aniseikonia introduced with 6% overall and 6% meridional (×180, ×90) magnifiers before the right eye; (2) Comparison of lens-induced and screen-induced 6% overall and meridional magnifications and (3) Determining if lens and screen effects neutralised, by opposing 6% lens-induced magnification to the right eye with screen-inducements of either 6% left eye magnification or 6% right eye minification. A pilot study of the effect of masking versus not masking the surround was also conducted. RESULTS: The 4-C test gave higher stereo-thresholds than the RDS test by 0.5 ± 0.2 log units across both anisometropic and aniseikonic conditions. However, variations in power, meridian and magnification affected the two tests similarly. The pilot study indicated that surround masking improved neutralisation of screen and lens effects. With masking, lens-induced and screen-induced magnifications increased stereo-thresholds similarly. With lens and screen effects opposed, for most participants stereo-thresholds returned to baseline for overall and ×180 magnifications, but not for ×90 magnification. Only three of seven participants showed good compensation for ×90 magnification. CONCLUSIONS: Effects of lens-induced aniseikonia on stereopsis cannot always be successfully simulated with a screen-based method. The ability to neutralise refractive aniseikonia using a computer-based method, which is the basis of digital clinical measurement, was reasonably successful for overall and ×180 meridional aniseikonia, but not very successful for ×90 aniseikonia.
Subject(s)
Aniseikonia , Aniseikonia/diagnosis , Depth Perception , Eyeglasses , Humans , Pilot Projects , Refraction, OcularABSTRACT
PURPOSE: To compare the surgical outcomes of epiretinal membranes (ERMs) associated with retinal break and idiopathic ERMs. METHODS: This retrospective study included patients with an idiopathic ERM or an ERM associated with retinal break, who were followed up for ≥ 6 months after ERM removal. The postoperative functional and anatomical outcomes were compared between the groups. RESULTS: A total of 160 and 38 eyes (198 patients) were in the idiopathic and retinal break groups, respectively. There was no significant difference in the baseline anatomical and functional parameters between the groups. At 6 months after surgery and at the final follow-up, best-corrected visual acuity, central foveal thickness, and ectopic inner foveal layer improved significantly in both groups, but there was no significant difference between the groups. In latter 49.0% of patients, tests for metamorphopsia and aniseikonia were performed. There was a significant improvement in the scores of metamorphopsia (0.40 ± 0.38 to 0.27 ± 0.28; p < 0.001) and aniseikonia (6.07 ± 4.46 to 4.11 ± 3.52; p < 0.001) in the idiopathic group at 6 months after surgery, but not in the retinal break group. The idiopathic group had significantly greater circularity of ERM extent compared to the retinal break group (p = 0.025). CONCLUSION: Visual and anatomical improvements after removal of ERMs associated with retinal break and idiopathic ERMs were comparable. However, metamorphopsia and aniseikonia improved only after removal of idiopathic ERMs.
Subject(s)
Aniseikonia , Epiretinal Membrane , Retinal Perforations , Aniseikonia/complications , Epiretinal Membrane/complications , Epiretinal Membrane/diagnosis , Epiretinal Membrane/surgery , Humans , Retinal Perforations/surgery , Retrospective Studies , Tomography, Optical Coherence , Treatment Outcome , Vision Disorders , Visual Acuity , VitrectomyABSTRACT
PURPOSE: To evaluate differences in the subjective aniseikonia and stereoacuity in patients with axial anisometropia after full correction of the refractive error with spectacles, contact lenses, and refractive surgery. METHODS: A prospective study was performed in Cairo University Hospitals on 20 patients with axial anisometropia caused by unilateral myopia > 5 D with > 4 D inter-ocular difference in spherical equivalent who were suitable candidates for excimer laser ablation (LASIK) or implantable collamer lens implantation (ICL). All patients had measurement of best-corrected visual acuity (BCVA), fusion, stereoacuity, and magnitude of aniseikonia with spectacles, contact lenses, and after surgery. RESULTS: The mean age at time of surgery was 25.7 ± 3.1 years. There were no statistically significant differences in the BCVA or stereoacuity with spectacles, contact lenses, or after refractive surgery. Microkonia < 5%) was perceived with spectacles in 8 patients (40%) and remained unchanged in 7 of these 8 patients with contact lenses. Following LASIK (n = 11), there was an induced macrokonia < 2% in 4 patients (36%), persistent microkonia of 3% in 1 patient (9%), and no change in image size in 6 (55%) patients. Following ICL implantation (n = 9), there was a perceived macrokonia of 2% in 4 patients (44%), disappearance of microkonia in 1 patient (11%) and no change in 4 patients (44%). CONCLUSIONS: Differences in BCVA, stereoacuity, and aniseikonia after correction of anisometropia by glasses, contact lens and surgery are both clinically and statistically insignificant. Retinal or neural adaptation might have a role in correction for differences in image size.
Subject(s)
Aniseikonia , Anisometropia , Keratomileusis, Laser In Situ , Aniseikonia/diagnosis , Aniseikonia/etiology , Aniseikonia/surgery , Anisometropia/surgery , Humans , Prospective Studies , Refraction, OcularABSTRACT
BACKGROUND AND PURPOSE: Aniseikonia as one of the major risk factors for asthenopic problems is mostly overlooked in modern cataract surgery. The purpose of this study was to develop a simple calculation scheme for clinicians to predict the object to image magnification in a pseudophakic eye with biometric data. METHODS: The calculation scheme for object to image magnification in the pseudophakic eye is based on a vergence calculation of the lens power with theoretical optical formulae. From the biometric data, which are typically derived from both eyes during lens power calculation, the vergences in front of and behind the 3 or 4 refractive surfaces of the pseudophakic eye model are used to predict the magnification for objects at infinity or objects located at a finite measurement distance (e.g. 5â¯m). RESULTS: With a formula-based lens power calculation a pseudophakic eye model is set up with 3 or 4 refractive surfaces (postoperative spectacle refraction; thick cornea described by anterior surface or thick cornea characterized by anterior and posterior surfaces; intraocular lens). The vergence in front of and behind each refractive surface is derived by means of linear Gaussian optics. The quotient of the product of all vergences in front of the surfaces and the product of all vergences behind the respective surfaces describes the object to image magnification of the eye. A comparison of the object to image magnification of both eyes yields the retinal image size disparity or aniseikonia. This calculation strategy is shown in a step-by-step approach exemplarily for the Haigis and HofferQ formulae (3 surfaces) and the Castrop formula (4 surfaces). CONCLUSION: If during planning and lens power calculation biometry is performed for both eyes, ocular magnification of both eyes can be easily derived with this calculation scheme and aniseikonia can be extracted from a comparison of magnification of both eyes. Such a simple prediction should be established as a standard for precataract biometry and lens power calculation for early detection and avoidance of asthenopic complaints after cataract surgery.
Subject(s)
Aniseikonia , Cataract Extraction , Cataract , Lenses, Intraocular , Aniseikonia/diagnosis , Biometry , Humans , Refraction, OcularABSTRACT
PURPOSE: To quantify stereopsis and other visual functions in patients with unilateral branch retinal vein occlusion (BRVO) and to investigate vision-related parameters that affect stereopsis. DESIGN: Prospective observational study. SUBJECTS: Forty-five patients undergoing intravitreal ranibizumab (IVR) treatment for unilateral BRVO. METHODS: We examined stereopsis using the Titmus stereo test (TST) and TNO stereotest (TNO), best corrected visual acuity (BCVA), letter contrast sensitivity, severity of metamorphopsia and degree of aniseikonia before and 6 months after IVR. MAIN OUTCOME MEASURES: Visual functions that affect stereopsis. RESULTS: Baseline stereopsis in patients with BRVO was 2.7 ± 0.6 (range, 1.6-3.5) in the TST and 2.8 ± 0.5 (range, 1.8-3.3) in TNO. TST and TNO scores were significantly correlated with BCVA and letter contrast sensitivity at baseline (P < 0.001) but not with other visual functions. IVR treatment significantly improved stereopsis, BCVA, and letter contrast sensitivity. After treatment, TST scores were significantly correlated with BCVA (P < 0.001), letter contrast sensitivity (P < 0.001), and aniseikonia (P < 0.01). TNO scores were significantly correlated with BCVA (P < 0.01) and letter contrast sensitivity (P < 0.01). TST and TNO scores after treatment were significantly correlated with BCVA at baseline (P < 0.01 for both). CONCLUSIONS: Deterioration of stereopsis in patients with BRVO was associated with changes in visual acuity and contrast sensitivity after treatment. Initial visual acuity is a prognostic factor for posttreatment stereopsis.
Subject(s)
Aniseikonia , Retinal Vein Occlusion , Angiogenesis Inhibitors/therapeutic use , Depth Perception , Humans , Intravitreal Injections , Ranibizumab/therapeutic use , Retinal Vein Occlusion/drug therapy , Tomography, Optical Coherence , Treatment Outcome , Visual AcuityABSTRACT
PURPOSE: To quantify aniseikonia following intravitreal ranibizumab (IVR) in patients with branch retinal vein occlusion (BRVO) and assess the relationship between aniseikonia and retinal microstructure. STUDY DESIGN: Prospective observational study. METHODS: This study included 50 patients undergoing IVR treatment for unilateral BRVO. The degree of aniseikonia and best-corrected visual acuity (BCVA) was examined, and retinal microstructure was assessed with optical coherence tomography (OCT) before and 1, 2, 3, 4, 5, and 6 months after treatment. Based on OCT images, we assessed central retinal thickness (CRT), presence of the epiretinal membrane, and serous retinal detachment (SRD), as well as status of the external limiting membrane and ellipsoid zone. RESULTS: At baseline, mean aniseikonia was - 1.0 ± 2.5%, ranging from - 11.0 to + 6.0%. Nine out of 50 patients had micropsia (18%), one had macropsia (2%), and 40 had no aniseikonia (80%). After 6 months of treatment, mean aniseikonia was - 0.7 ± 1.5%, ranging from - 4.5 to + 3.5%. BCVA significantly improved after treatment (P < 0.001), but aniseikonia did not change (P = 0.73). In patients with BRVO who had micropsia (≤ - 2.0%) at baseline, mean aniseikonia significantly improved from - 4.8 ± 3.3% to - 0.9 ± 1.4% (P < 0.05). Aniseikonia after treatment significantly correlated with BCVA (P < 0.05) and the presence of SRD at baseline (P < 0.05). CONCLUSION: Majority of eyes with aniseikonia in BRVO had micropsia. The BCVA as well as the micropsia improved following treatment with IVR for BRVO. BCVA and the presence of SRD were predictors of post-treatment aniseikonia.